The Enterprise Value as of November 2024 (TTM) for Telix Pharmaceuticals Limited (TLPPF) is 7.11B

According to Telix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 7.11B. This represents a change of 64.66% compared to the average of 4.32B of the last 4 quarters.

Telix Pharmaceuticals Limited (TLPPF) Historical Enterprise Value (quarterly & annually)

How has TLPPF Enterprise Value performed in the past?

The mean historical Enterprise Value of Telix Pharmaceuticals Limited over the last ten years is 910.96M. The current 7.11B Enterprise Value has changed 77.93% with respect to the historical average. Over the past ten years (40 quarters), TLPPF's Enterprise Value was at its highest in in the June 2024 quarter at 6.14B. The Enterprise Value was at its lowest in in the June 2017 quarter at -2410001.58.

Telix Pharmaceuticals Limited (TLPPF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Telix Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Telix Pharmaceuticals Limited (TLPPF) Average Enterprise Value

How has TLPPF Enterprise Value performed in the past?

The current Enterprise Value of Telix Pharmaceuticals Limited (TLPPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Telix Pharmaceuticals Limited (TLPPF) Enterprise Value vs. Peers

How is TLPPF’s Enterprise Value compared to its peers?

Telix Pharmaceuticals Limited’s Enterprise Value is greater than Genscript Biotech Corporation (3.49B), greater than Keros Therapeutics, Inc. (1.75B), greater than Zentalis Pharmaceuticals, Inc. (229.32M), less than Innovent Biologics, Inc. (51.12B), greater than MAIA Biotechnology, Inc. (41.04M), greater than Graphite Bio, Inc. (-15007658.00), less than Roivant Sciences Ltd. (7.20B), greater than Field Trip Health & Wellness Ltd. (3.71M), greater than Nautilus Biotechnology, Inc. (328.51M), greater than Arcellx, Inc. (4.79B), greater than Ventyx Biosciences, Inc. (80.09M), greater than Immunocore Holdings plc (1.56B), less than Vaxcyte, Inc. (10.01B), greater than DICE Therapeutics, Inc. (1.82B),

Build a custom stock screener for Telix Pharmaceuticals Limited (TLPPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Telix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Telix Pharmaceuticals Limited (TLPPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Telix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.